Proposed Rule2023-19070
Medicare Program: Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 5, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Medicare & Medicaid Services
Abstract
This document extends the comment period for the proposed rule titled "Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022" that was published in the July 11, 2023 Federal Register. The comment period for the proposed rule, which would otherwise end on September 5, 2023, is extended until September 11, 2023.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 170 (Tuesday, September 5, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 170 (Tuesday, September 5, 2023)]
[Proposed Rules]
[Pages 60610-60611]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19070]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Part 419
[CMS-1793-N]
RIN 0938-AV18
Medicare Program: Hospital Outpatient Prospective Payment System:
Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years
2018-2022; Extension of Comment Period
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (HHS).
ACTION: Proposed rule; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: This document extends the comment period for the proposed rule
titled ``Medicare Program; Hospital Outpatient Prospective Payment
System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar
Years 2018-2022'' that was published in the July 11, 2023 Federal
Register. The comment period for the proposed rule, which would
otherwise end on September 5, 2023, is extended until September 11,
2023.
DATES: The comment period for the proposed rule published at 88 FR
44078 on July 11, 2023, is extended to 5 p.m., Eastern Daylight Time,
on September 11, 2023.
ADDRESSES: You may submit comments as outlined in the July 11, 2023,
proposed rule (88 FR 44078). Please choose only one method listed.
FOR FURTHER INFORMATION CONTACT: Cory Duke, (410) 786-0631 or
<a href="/cdn-cgi/l/email-protection#99daf6ebe0b7ddecf2fcd9faf4eab7f1f1eab7fef6ef"><span class="__cf_email__" data-cfemail="9ddef2efe4b3d9e8f6f8ddfef0eeb3f5f5eeb3faf2eb">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow the search instructions on that website to
view public comments. CMS will not post on <a href="http://Regulations.gov">Regulations.gov</a> public
comments that make threats to individuals or institutions or suggest
that the individual will take actions to harm the individual. CMS
continues to encourage individuals not to submit duplicative comments.
We will post acceptable comments from multiple unique commenters even
if the content is identical or nearly identical to other comments.
In the July 11, 2023 Federal Register (88 FR 44078), we published a
proposed rule titled ``Medicare Program; Hospital Outpatient
Prospective Payment System: Remedy for the 340B-Acquired Drug Payment
Policy for Calendar Years 2018-2022.'' The proposed rule announced a
comment period ending on September 11, 2023.
Subsequently, a correction was published in the July 14, 2023
Federal Register (88 FR 45126), which changed the comment period end
date from ``September 11, 2023'' to ``September 5, 2023''. This change
was made because September 5, 2023, was the correct comment period end
date based on the comment period ending 60 days after the initial
display date (July 7, 2023) of the proposed rule.
However, we subsequently became aware of public confusion over the
end date of the comment period. In order to eliminate this confusion
and maximize the opportunity for the public to provide meaningful input
to CMS, we believe it is important to allow additional time for the
public to prepare comments on the July 2023 proposed rule. Therefore,
we are extending the comment period for the proposed rule by 6 days.
This document announces the extension of the public comment period for
the proposed rule, which will now end at 5 p.m., Eastern Daylight Time,
on September 11, 2023.
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Vanessa Garcia, who is the Federal Register
Liaison, to electronically sign this document for
[[Page 60611]]
purposes of publication in the Federal Register.
Dated: August 30, 2023.
Vanessa Garcia,
Federal Register Liaison, Centers for Medicare and Medicaid Services.
[FR Doc. 2023-19070 Filed 8-31-23; 4:15 pm]
BILLING CODE 4120-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 5, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.